Virtual echocardiography screening tool scores calculated via algorithm matched manually calculated scores and are promising ...

Chronic thromboembolic pulmonary hypertension (CTEPH) is the clinical term for high blood pressure in the lungs caused by blockages, such as clots, in the blood vessels. Although CTEPH therapies have ...

Clinicians managing kidney transplant candidates with pulmonary hypertension need to be aware of possible excess risks.

An agency-sponsored forum included critics of psychiatry who believe the drugs can harm a developing fetus. Other experts ...

The disease primarily affects middle-aged women and has a poor long-term prognosis despite therapeutic advances.

Researchers from the Japanese National Cerebral and Cardiovascular Center have found that the 5-year survival rates of patients with chronic thromboembolic pulmonary hypertension at their center ...

United Therapeutics Corporation (NASDAQ:UTHR) is among the most undervalued stocks to invest in. It is a biotechnology ...

From diagnosis methods to management of comorbid infections, new lung cancer protocols adaptable for various conditions ...

There is increased risk for pulmonary hypertension in patients with both atrial fibrillation and incident venous thromboembolism.

Panelists discuss how the future of PAH treatment looks promising with potential for disease remission through reverse remodeling agents, emphasizing the need for continued research focus on patients ...

Pulmonary Hypertension associated with Interstitial Lung Disease Market Insight, Epidemiology And Market Forecast - 2034The pulmonary hypert ...

Pulmonary arterial hypertension (PAH) is a rare, progressive disorder impacting small pulmonary arteries, leading to increased vascular resistance and heart failure. The latest report forecasts ...